https://www.selleckchem.com/pr....oducts/pd-1-pd-l1-in
09). Compared to placebo, patients in the ANG-3777 arm had larger increases in urine output; lower SCr; greater reduction in C-reactive protein (CRP) and neutrophil gelatinase-associated lipocalin (NGAL); fewer dialysis sessions and shorter duration of dialysis; fewer hospital days; significantly less graft failure; and higher eGFR. Adverse events occurred in a similar percentage of subjects in both arms. Events per subject were twice as high in the placebo arm. CONCLUSIONS There was an efficacy signal for improved renal
Like
Comment
Share
